China Pharma Holdings (CHPI) Annual Balance Sheets

Annual · GAAP · USD millions
Access CHPI quarterly Balance Sheets →
A period-by-period view of the balance sheet from China Pharma Holdings to helps clarify how Dec 31 2010's financial structure has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2010)
Assets
Cash & cash equivalent0.34
Cash & Short-term Investments0.00
Accounts receivable2.32
Inventories0.13
Prepaid Expense And Other Assets Current0.01
Total Current Assets3.24
Equipment/Property/Plant Net1.39
Intangible Assets1.84
Total Assets6.47
Liabilities
Accounts Payable0.13
Accrued Liabilities, Current AC0.43
Notes Payable, Current NO0.53
Accrued Income Taxes, Current TA0.17
Deferred Revenue DE0.06
Total Current Liabilities1.32
Long-term debt0.21
Total Long-term Debt0.21
Total Liabilities1.53
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock0.80
Retained Earnings / Accumulated Deficit3.86
Accumulated Other Comprehensive Income0.23
Other Equity0.23
Common Stockholder's Equity4.93
Total Stockholder's Equity4.93
Liabilities & Stockholder's Equity6.47
4 historic quarters locked

Sign in to unlock the full China Pharma Holdings balance sheet history.

About CHPI Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.